Tools to Guide Risk Assessment and Adjuvant Treatment Decisions in HR-positive, HER2-negative Early Breast Cancer: A Focus on Best Practices (ID 437)
Lecture Time
12:30 - 12:30
Speakers
- All Speakers (na, Swaziland)
Authors
- All Speakers (na, Swaziland)